Gregory A. Abel
Assistant Professor
Hematologic OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.
Research Interest
Leukemia, Myelodysplastic syndromes, Myeloproliferative disorders
Publications
-
Abel, G. A., Chen, K., Taback, N., Hassett, M. J., Schrag, D., & Weeks, J. C. (2013). Impact of oncologyâ€related directâ€toâ€consumer advertising. Cancer, 119(5), 1065-1072.
-
Abel, G. A., Neufeld, E. J., Sorel, M., & Weeks, J. C. (2008). Directâ€toâ€consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. Journal of Thrombosis and Haemostasis, 6(10), 1680-1684.
-
Kumar, A., Vanderplas, A., LaCasce, A. S., Rodriguez, M. A., Crosby, A. L., Lepisto, E., ... & Millenson, M. (2012). Lack of benefit of central nervous system prophylaxis for diffuse large Bâ€cell lymphoma in the rituximab era. Cancer, 118(11), 2944-2951.
